IGF2 antibody (AA 25-180)
-
- Target See all IGF2 Antibodies
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
-
Binding Specificity
- AA 25-180
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This IGF2 antibody is un-conjugated
-
Application
- Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Purpose
- IGF2 Antibody
- Purification
- Purified antibody
- Immunogen
- Purified recombinant fragment of human IGF2 (AA: 25-180) expressed in E. Coli.
- Clone
- 8H1
- Isotype
- IgG1
-
-
- Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, Vol. 16, Issue 4, pp. 346-54, (2011) (PubMed).
: "Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer." in: Journal of cancer research and clinical oncology, Vol. 137, Issue 2, pp. 339-45, (2011) (PubMed).
: "
-
Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, Vol. 16, Issue 4, pp. 346-54, (2011) (PubMed).
-
- Target
- IGF2 (Insulin-Like Growth Factor 2 (IGF2))
- Alternative Name
- IGF2 (IGF2 Products)
- Synonyms
- C11orf43 antibody, IGF-II antibody, PP9974 antibody, LOC100136550 antibody, igf2 antibody, igf2b antibody, wu:fc26e03 antibody, zgc:91781 antibody, igf-2 antibody, insigf antibody, pp9974 antibody, AL033362 antibody, Igf-2 antibody, Igf-II antibody, M6pr antibody, Mpr antibody, Peg2 antibody, IGFII antibody, RNIGF2 antibody, IGF-II-B antibody, igf2-a antibody, igf2-b antibody, insulin like growth factor 2 antibody, insulin-like growth factor II antibody, insulin-like growth factor 2a antibody, insulin like growth factor 2 S homeolog antibody, insulin-like growth factor 2 antibody, insulin-like growth factor 2 (somatomedin A) antibody, insulin like growth factor 2 L homeolog antibody, IGF2 antibody, LOC100136550 antibody, igf2a antibody, igf2.S antibody, Igf2 antibody, igf2.L antibody
- Background
-
Description: This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Aliases: IGF-II, PP9974, C11orf43, FLJ22066, FLJ44734
- Molecular Weight
- 20.1kDa
- Gene ID
- 3481
- HGNC
- 3481
- UniProt
- P01344
- Pathways
- Hormone Activity, Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Regulation of Carbohydrate Metabolic Process, Activated T Cell Proliferation
-